Skip to content

Study of Tocotrienol Absorption and Distribution Under Different Fat Status

Mechanism of Absorption and Distribution of Tocotrienols Under Different Food Status

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01185769
Enrollment
10
Registered
2010-08-20
Start date
2009-09-30
Completion date
2009-09-30
Last updated
2010-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Absorption

Keywords

Vitamin E, Absorption

Brief summary

Despite the emerging interest in tocotrienols, the absorption of tocotrienols in humans remains unclear especially with different fat diets.This study aimed at evaluating the absorption and distribution of tocotrienols in plasma and lipoproteins in associations with high and low fat diets. Different fat level will affect the absorption and distribution of tocotrienols

Detailed description

There is a possibility that the absorption and distribution of tocotrienols may occur differently compared with tocopherols, especially under different fat status

Interventions

DIETARY_SUPPLEMENTTocotrienol

500 mg of tocotrienol will be administered after consumption of high fat diet

Sponsors

University of Malaya
CollaboratorOTHER
Malaysia Palm Oil Board
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
22 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* male aged 22-25 * body mass index 18.5 \< X \< 30 kg/m2 * plasma cholesterol \< 5.2 mmol/L, * TAG \< 1.7 mmol/L

Exclusion criteria

* history of cardiovascular disease * diabetic * body mass index \< 18.5 or \> 30 kg/m2 * plasma cholesterol \> 5.2 mmol/L, * TAG \> 1.7 mmol/L * hypertension * currently taking Vitamin E supplement * current use of medication * smoking.

Design outcomes

Primary

MeasureTime frame
Difference in absorption and distribution of Tocoterienols during high fat and low fat meal by measuring the plasma, chylomicron, and HDL level of tocotrienol0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 24 hours after tocotrienol administration and in take of designated meal

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026